Variant report
Variant | nsv981163 |
---|---|
Chromosome Location | chr6:87606791-87613920 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:16)
- CpG islands (count:305)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:16 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr6:87608120-87608193 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | EGR1 | chr6:87608082-87608207 | GM12878 | blood: | n/a | n/a |
3 | FOXA1 | chr6:87607744-87608000 | HepG2 | liver: | n/a | n/a |
4 | FOXA2 | chr6:87607661-87608167 | A549 | lung: | n/a | n/a |
5 | FOXA2 | chr6:87607600-87608282 | A549 | lung: | n/a | n/a |
6 | GABPA | chr6:87608077-87608242 | GM12878 | blood: | n/a | n/a |
7 | MAZ | chr6:87613711-87613911 | HepG2 | liver: | n/a | n/a |
8 | MYC | chr6:87607797-87607879 | MCF-7 | breast: | n/a | n/a |
9 | POLR2A | chr6:87607687-87607984 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | POLR2A | chr6:87608048-87608199 | MCF-7 | breast: | n/a | n/a |
11 | POLR2A | chr6:87607795-87607803 | MCF-7 | breast: | n/a | n/a |
12 | POLR2A | chr6:87607867-87607879 | MCF-7 | breast: | n/a | n/a |
13 | REST | chr6:87608114-87608216 | PANC-1 | pancreas: | n/a | n/a |
14 | SRF | chr6:87608110-87608242 | GM12878 | blood: | n/a | n/a |
15 | TAF1 | chr6:87607693-87607992 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | USF1 | chr6:87608077-87608217 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:87607178-87607228 | H1-hESC | embryonic stem cell: | embryo |
2 | chr6:87607655-87607705 | Jurkat | blood: | n/a |
3 | chr6:87607655-87607705 | HPAEpiC | pulmonary alveolar: | n/a |
4 | chr6:87607655-87607705 | HIPEpiC | eye: | n/a |
5 | chr6:87607161-87607211 | HEK293 | kidney: | embryo |
6 | chr6:87607161-87607211 | HMEC | breast: | n/a |
7 | chr6:87607161-87607211 | Hepatocyte | liver: | n/a |
8 | chr6:87607161-87607211 | LNCaP | prostate: | n/a |
9 | chr6:87607161-87607211 | H1-hESC | embryonic stem cell: | embryo |
10 | chr6:87607161-87607211 | Caco-2 | colon: | n/a |
11 | chr6:87607744-87607794 | PANC-1 | pancreas: | n/a |
12 | chr6:87607178-87607228 | NHBE | bronchial: | n/a |
13 | chr6:87607655-87607705 | GM12878 | blood: | n/a |
14 | chr6:87607655-87607705 | AoSMC | blood vessel: | n/a |
15 | chr6:87607178-87607228 | GM19239 | blood: | n/a |
16 | chr6:87607178-87607228 | T-47D | breast: | n/a |
17 | chr6:87607195-87607245 | PFSK-1 | brain: | n/a |
18 | chr6:87607744-87607794 | AoSMC | blood vessel: | n/a |
19 | chr6:87607195-87607245 | ovcar-3 | ovarian: | n/a |
20 | chr6:87607195-87607245 | HCPEpiC | choroid plexus: | n/a |
21 | chr6:87607744-87607794 | AG09319 | gingival: | n/a |
22 | chr6:87607744-87607794 | IMR90 | lung: | fetal |
23 | chr6:87607195-87607245 | HCF | heart: | n/a |
24 | chr6:87607655-87607705 | ovcar-3 | ovarian: | n/a |
25 | chr6:87607178-87607228 | HRPEpiC | eye: | n/a |
26 | chr6:87607161-87607211 | HUVEC | blood vessel: | n/a |
27 | chr6:87607178-87607228 | NH-A | brain: | n/a |
28 | chr6:87607195-87607245 | NHBE | bronchial: | n/a |
29 | chr6:87607178-87607228 | PrEC | prostate: | n/a |
30 | chr6:87607744-87607794 | Caco-2 | colon: | n/a |
31 | chr6:87607195-87607245 | HUVEC | blood vessel: | n/a |
32 | chr6:87607178-87607228 | HRCEpiC | kidney: | n/a |
33 | chr6:87607744-87607794 | AG04450 | lung: | fetal |
34 | chr6:87607655-87607705 | AG09319 | gingival: | n/a |
35 | chr6:87607744-87607794 | SAEC | small airway: | n/a |
36 | chr6:87607161-87607211 | SAEC | small airway: | n/a |
37 | chr6:87607655-87607705 | SK-N-MC | brain: | n/a |
38 | chr6:87607178-87607228 | GM12878 | blood: | n/a |
39 | chr6:87607178-87607228 | HMEC | breast: | n/a |
40 | chr6:87607744-87607794 | CMK | blood: | n/a |
41 | chr6:87607178-87607228 | HNPCEpiC | eye: | n/a |
42 | chr6:87607195-87607245 | H1-hESC | embryonic stem cell: | embryo |
43 | chr6:87607161-87607211 | HCM | heart: | n/a |
44 | chr6:87607655-87607705 | SKMC | muscle: | n/a |
45 | chr6:87607195-87607245 | LNCaP | prostate: | n/a |
46 | chr6:87607195-87607245 | Hela-S3 | cervix: | n/a |
47 | chr6:87607744-87607794 | HL-60 | blood: | n/a |
48 | chr6:87607655-87607705 | HRCEpiC | kidney: | n/a |
49 | chr6:87607655-87607705 | AG04449 | skin: | fetal |
50 | chr6:87607195-87607245 | HAEpiC | amniotic membrane: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000217769 | TF binding region |
ENSG00000220240 | TF binding region |
ENSG00000217769 | CpG island |
ENSG00000220240 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374941372 | chr6:87607162-87607163 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs386703485 | chr6:87607168-87607169 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs72912421 | chr6:87607169-87607170 | Inactive region | CpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs571283353 | chr6:87607178-87607179 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs538759310 | chr6:87607179-87607180 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs145224786 | chr6:87607180-87607181 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs572262252 | chr6:87607187-87607188 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs181766279 | chr6:87607191-87607192 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs554804118 | chr6:87607195-87607196 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs576270781 | chr6:87607196-87607197 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs544560546 | chr6:87607198-87607199 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs147600746 | chr6:87607208-87607209 | Bivalent/Poised TSS Bivalent Enhancer | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs533184152 | chr6:87607209-87607210 | Bivalent/Poised TSS Bivalent Enhancer | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs35739186 | chr6:87607219-87607220 | Bivalent/Poised TSS Bivalent Enhancer | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs545084525 | chr6:87607222-87607223 | Bivalent/Poised TSS Bivalent Enhancer | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs140404169 | chr6:87607227-87607228 | Bivalent/Poised TSS Bivalent Enhancer | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs527874394 | chr6:87607231-87607232 | Bivalent/Poised TSS Bivalent Enhancer | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs200437091 | chr6:87607244-87607245 | Bivalent/Poised TSS Bivalent Enhancer | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs549314681 | chr6:87607248-87607249 | Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114374613 | chr6:87607278-87607279 | Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs9450568 | chr6:87607330-87607331 | Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs549719765 | chr6:87607341-87607342 | Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs61742890 | chr6:87607349-87607350 | Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs61742892 | chr6:87607358-87607359 | Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144263336 | chr6:87607376-87607377 | Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565787175 | chr6:87607394-87607395 | Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536408833 | chr6:87607397-87607398 | Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs554484000 | chr6:87607421-87607422 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs13194114 | chr6:87607444-87607445 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183043185 | chr6:87607445-87607446 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558847577 | chr6:87607467-87607468 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs151146528 | chr6:87607477-87607478 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112737344 | chr6:87607478-87607479 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112314866 | chr6:87607484-87607485 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150489907 | chr6:87607487-87607488 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186724261 | chr6:87607488-87607489 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543170232 | chr6:87607495-87607496 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113321157 | chr6:87607506-87607507 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35633024 | chr6:87607527-87607528 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370596418 | chr6:87607539-87607540 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
41 | rs183125320 | chr6:87607554-87607555 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
42 | rs367913988 | chr6:87607561-87607562 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565628449 | chr6:87607562-87607563 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9450569 | chr6:87607577-87607578 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs141375073 | chr6:87607584-87607585 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565748670 | chr6:87607585-87607586 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537034731 | chr6:87607588-87607589 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9450570 | chr6:87607589-87607590 | Active TSS Bivalent/Poised TSS Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs569737738 | chr6:87607603-87607604 | Active TSS Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs376883784 | chr6:87607612-87607613 | Active TSS Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
abnormal development | 18461090 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 19490664 | CNVD |
Schizophrenia | 23813976 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:87607200-87607400 | Bivalent/Poised TSS | ES-I3 Cell Line | embryonic stem cell |
2 | chr6:87607200-87607400 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
3 | chr6:87607200-87607400 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
4 | chr6:87607200-87607400 | Bivalent Enhancer | iPS-20b Cell Line | embryonic stem cell |
5 | chr6:87607200-87607600 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
6 | chr6:87607200-87607600 | Bivalent/Poised TSS | HUES6 Cell Line | embryonic stem cell |
7 | chr6:87607200-87607600 | Bivalent/Poised TSS | iPS-15b Cell Line | embryonic stem cell |
8 | chr6:87607200-87607800 | Bivalent/Poised TSS | iPS-18 Cell Line | embryonic stem cell |
9 | chr6:87607400-87607600 | Bivalent/Poised TSS | ES-WA7 Cell Line | embryonic stem cell |
10 | chr6:87607400-87607600 | Bivalent/Poised TSS | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
11 | chr6:87607400-87607600 | Bivalent/Poised TSS | HUES48 Cell Line | embryonic stem cell |
12 | chr6:87607400-87607600 | Bivalent/Poised TSS | iPS-20b Cell Line | embryonic stem cell |
13 | chr6:87607400-87608000 | Active TSS | H9 Cell Line | embryonic stem cell |
14 | chr6:87607400-87608000 | Active TSS | HUES64 Cell Line | embryonic stem cell |
15 | chr6:87607400-87608400 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
16 | chr6:87607600-87607800 | Active TSS | H1 Cell Line | embryonic stem cell |
17 | chr6:87607600-87608000 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
18 | chr6:87607600-87608200 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
19 | chr6:87607600-87608200 | Active TSS | HUES48 Cell Line | embryonic stem cell |
20 | chr6:87607600-87608400 | Active TSS | HUES6 Cell Line | embryonic stem cell |
21 | chr6:87607600-87608400 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
22 | chr6:87608400-87608600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |